In the said study, four breast cancer cell lines with variable levels of the expression of these two markers were used to research the effects of metformin used in vitro, including MCF-7 and MCF-7/713 (MCF-7 transfected with erbB2, BT-474, and SKBR-3) [13]. The gene discussed is ERBB2; the disease is breast carcinoma.